Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomi...

by Strand, Vibeke, Fiorentino, David, Hu, ChiaChi, Day, Robert M, Stevens, Randall M, Papp, Kim A
Published 2013

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

by Kavanaugh, Arthur, Mease, Philip J, Gomez-Reino, Juan J, Adebajo, Adewale O, Wollenhaupt, Jürgen, Gladman, Dafna D, Lespessailles, Eric, Hall, Stephen, Hochfeld, Marla, Hu, ChiaChi, Hough, Douglas, Stevens, Randall M, Schett, Georg
Published 2014